Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Sandra Margetić

27012

Sandra

Margetić

dr. sc.

Naziv Uloga Akcije
Novi oralni antikoagulansi: povezanost koncentracije lijeka i antikoagulantnog učinka voditelj
Naziv Akcije
Ivanko, Iva; Ćelap, Ivana; Margetić, Sandra; Marijančević, Domagoj; Vahtarić, Antonio; Josipović, Josipa; Gaćina, Petar Evaluation of Proinflammatory and Haemostasis Markers after BNT162b2 SARS-CoV-2 Vaccination // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 408-409 doi: 10.1016/j.rpth.2023.100860
Ćelap, Ivana; Margetić, Sandra; Džudović, Jelena; Razum, Marija Comparison of rivaroxaban concentrations measured by anti-Xa rivaroxaban calibrated assay and LC-MS/MS // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 467-467 doi: 10.1016/j.rpth.2023.100953
Ćelap, Ivana; Ivanko, Iva; Margetić, Sandra; Stojanović, Ivana Combined DOAC and antiplatelet therapy caused menorrhagia in young woman - case report // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 460-461 doi: 10.1016/j.rpth.2023.100942
Ivanko, Iva; Ćelap, Ivana; Margetić, Sandra; Marijančević, Domagoj; Josipović, Josipa; Gaćina, Petar Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination // Thrombosis research, 228 (2023), 8; 137-144. doi: 10.1016/j.thromres.2023.06.008
Ćelap, Ivana; Margetić, Sandra; Mihić, Roman; Razum, Marija Reporting of DOAC concentration as FXa inhibitory units: a possible solution for smaller laboratories // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 486-486 doi: 10.1016/j.rpth.2023.100979
Margetić, Sandra; Ćelap, Ivana; Razum, Marija, Tomić, Franciska; Šupraha-Goreta, Sandra Presentation of Four Real-Life Patients with Persistently Low Both Peak and Trough Direct Oral Anticoagulant Levels in Plasma: Potential Effect of Drug-Drug Interactions // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 446-446 doi: 10.1016/j.rpth.2023.100951
Margetić, Sandra; Bronić, Ana; Magdić Turković, Tihana; Tomić, Franciska; Ćelap, Ivana Concentrations of direct oral anticoagulants acting as FXa inhibitors could not be accurately determined in patients treated with therapeutic doses of low molecular heparin as bridging therapy // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 458-459 doi: 10.1016/j.rpth.2023.100939
Margetić, Sandra; Ćelap, Ivana; Obuljen, Jasna; Leniček Krleža, Jasna; Linarić, Irena; Tomić, Franciska; Razum, Marija Peak plasma concentrations of apixaban in children, adolescents and young adults with different dosing regimens applied // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 502-503 doi: 10.1016/j.rpth.2023.101004
Margetić, Sandra; Razum, Marija; Tomić, Franciska; Tešija Kuna, Andrea; Vukasović, Ines; Hanžek, Milena; Sušić, Tamara Antiphospholipid Antibodies in Unselected Consecutive Patients Referred for Testing // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 466-467 doi: 10.1016/j.rpth.2023.100952
Vuga, Ivana ; Vukasović, Ines ; Milevoj Kopčinović, Lara ; Bronić, Ana ; Tomić, Franciska ; Margetić, Sandra Izvještavanje ukupnog broja stanica s jezgrom uz broj leukocita u različitim vrstama ekstravaskularnih uzoraka – analiza rizika // Biochemia Medica. 2022. str. S68-S69
nije evidentirano
nije evidentirano